Amber Pharmacy

Name

Amber Pharmacy

Legal name

Amber Enterprises, Inc.

Website

https://amberpharmacy.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Specialty Pharmacy Services

NAICS

Pharmacies and Drug Retailers (456110)

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)

akta.pro secondary industries

Specialty Pharmacies (Complex/High-Cost Therapies) (HLAFALAC), Infusion & Home Infusion Pharmacy Services (HLAFALAG), Pharmacy Interoperability, Standards & Integration (FHIR/NCPDP) (HLACAKAO), In-Home Infusion Pharmacy Support & Coordination (HSABALAH)

Keywords

• Specialty pharmacy services
• Transplant medication dispensing
• Infusion therapy coordination
• 340B program management
• Chronic disease pharmacy

Headquarters

HQ city

Omaha

HQ country

United States

HQ region

North America

Offices7 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Specialty Pharmacy Dispensing: Amber Specialty Pharmacy dispenses specialty and transplant medications to patients with chronic, complex conditions. Revenue is generated through reimbursement from commercial insurance, Medicare Part B and D, Medicaid plans, and patient co-pays. The pharmacy coordinates benefits and billing with multiple payers.
2. 340B Program Services: Amber provides 340B hospital program management services including account management, program customization, and compliance support for covered entities.
3. Infusion Services: Full-service infusion therapy coordination including in-home administration with nationwide network of nurse partners. Services added in 2018.
4. Patient Assistance Programs: The company helps patients access financial assistance through manufacturer co-pay cards, grants, and foundations. While not a direct revenue stream, this supports patient access and reimbursement.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Core offering

Amber Specialty Pharmacy dispenses specialty and transplant medications to patients with chronic, complex conditions across rare disease, oncology, immunology, neurology, fertility, and transplant specialties, supported by 24/7 clinical care, condition-specific Centers of Excellence, financial assistance coordination, and nationwide shipping. The company also provides full-service infusion therapy coordination, a 340B hospital program management offering, and patient/provider digital tools (patient portal, mobile app, provider portal) for care coordination.

Product overview

Amber Specialty Pharmacy operates as a specialty pharmacy platform with multiple integrated products and services. The core offering is the Amber Specialty Pharmacy platform providing specialized medication dispensing and patient care for chronic, complex conditions. This is supported by patient-facing digital products including the Mobile App (iOS/Android) and Patient Portal (my.amberpharmacy.com), as well as provider-facing tools including the Provider Portal (providers.amberpharmacy.com). Additional service modules include Infusion Services for in-home administration and the 340B Hospital Program for hospital partners. The company serves patients through a network of pharmacy locations across the United States with coverage in all 50 states plus Puerto Rico.

Differentiator

Problem solved

Functional benefit

Brands

• Promises Programs: A comprehensive patient education and resources program offering personalized patient care and clinical support to promote medication adherence and compliance.

Products and services

• Amber Specialty Pharmacy (Specialty and Transplant Medication Dispensing) A specialty pharmacy providing specialized medication dispensing and personalized care for patients with chronic, complex medical conditions across rare disease, oncology, immunology, neurology, fertility, infusion, and transplant specialties. Includes 24/7 clinical support, condition-specific Centers of Excellence, financial assistance coordination, care coordination, and nationwide direct-to-patient shipping.
• Amber Specialty Pharmacy Mobile App A mobile application enabling patients to manage prescriptions on iOS and Android, including prescription status tracking, refill ordering, customized dose reminders, order tracking with real-time status, delivery tracking, profile management, live chat with patient care specialists, and access to condition-specific educational resources.
• Patient Portal Online patient portal allowing patients to manage accounts, order prescription refills, check delivery status, make payments, and access clinical support and pharmacy services.
• Provider Portal Web portal for healthcare providers to track referral status, monitor shipments, ensure patients received their medications, and receive provider notifications.
• Infusion Services Full-service infusion therapy coordination including in-home administration through a nationwide network of nurse partners, with ambulatory infusion capabilities and same-day DoorDash delivery for nearby patients.
• 340B Hospital Program A specialized program offering 340B Drug Pricing Program guidance and solutions for hospital partners, including dedicated account management, program customization, provider assistance with prior authorizations, financial assistance coordination, and audit support.
• BRINSUPRI (brensocatib) Limited Distribution Dispensing Specialty pharmacy dispensing service for BRINSUPRI (brensocatib), the first FDA-approved treatment for non-cystic fibrosis bronchiectasis in adults and adolescents, with rapid access, personalized counseling, and comprehensive reimbursement support.
• TZIELD (teplizumab) Limited Distribution Dispensing Specialty pharmacy dispensing service for TZIELD (teplizumab), an anti-CD3 monoclonal antibody infusion therapy to delay onset of Stage 3 Type 1 Diabetes in eligible pediatric and adolescent patients with Stage 2 T1D, supported by Amber's infusion-focused service model.
• REZUROCK (belumosudil) Limited Distribution Dispensing Specialty pharmacy dispensing service for REZUROCK (belumosudil), an oral therapy for chronic graft-versus-host disease (cGVHD), provided through a limited distribution network supporting bone marrow transplant providers and patients.

Quantifiable outcome

• 100% patient satisfaction rate in Q4 2016 Zitter Health Insights Patient Satisfaction Survey
• +3 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Partnerships

Five partnerships are on record, tiered minor and core.

• AsembiaminorGTM or Marketing Partner · 26 April 2026Amber Specialty Pharmacy participates in Asembia's AXS26 Summit (April 26-30, 2026 in Las Vegas). Company president & CEO moderates panel on role of specialty pharmacies in assisting underinsured patients.
• InsmedcoreStrategic or Co-development Partner · 12 August 2025Amber Specialty Pharmacy was selected to dispense BRINSUPRI (brensocatib) following FDA approval as the first treatment specifically indicated to reduce pulmonary exacerbations in adults and adolescents with non-cystic fibrosis bronchiectasis. Provides rapid access, personalized counseling, and comprehensive reimbursement support.
• Provention Bio, Inc.coreStrategic or Co-development Partner · 21 November 2022Amber Specialty Pharmacy was selected to dispense TZIELD (teplizumab), an anti-CD3 monoclonal antibody treatment to delay Stage 3 Type 1 Diabetes in patients ages 8 years and older with Stage 2 T1D. The partnership supports provider offices and appropriate patients with Stage 2 T1D across the country with infusion-focused service model and ambulatory/home infusion capabilities.
• KadmoncoreStrategic or Co-development Partner · 10 August 2021Amber Specialty Pharmacy was selected as one of three specialty pharmacies to dispense REZUROCK (belumosudil) tablets for chronic graft-versus-host disease (cGVHD) as part of a limited distribution network. The partnership supports oncology and bone marrow transplant providers and patients throughout the country.
• WeInfuseminorStrategic or Co-development PartnerWeInfuse partnership for infusion therapy services. Amber Specialty Pharmacy named partner of WeInfuse, providing enhanced infusion solutions for home infusion providers and healthcare partners.

Scale indicators10 records

Recent moves8 records

Expansion highlights6 records

Market position

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/amberpharmacy
• Facebookfacebook.com/amberpharmacy
• LinkedInlinkedin.com/company/880331

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Amber Pharmacy